Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12619000408189Phase 4Not yet recruiting
Phase 4 trial of artemether, lumefantrine and primaquine, sponsored by Ministry of Health. Planned start Apr 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12619000408189.